EBVALLO 2.8 x 10 000 000 - 7.3 x 10 000 000 cells/ml, injectable dispersion 6 bottles of 1 ml
Active ingredients: TABÉLECLEUCEL
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Injectable dispersion6 bottles of 1 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EBVALLO 2,8 x 10 000 000 - 7,3 x 10 000 000 cellules/mL, dispersion injectable
- Pharmaceutical form
- dispersion injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 à 6 flacons copolymère de cyclooléfines (COC) de 1 mL
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Jul 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66829076CIP75509465CIP133400955094654Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TABÉLECLEUCELdispersion | 2,8 x 10 000 000 - 7,3 x 10 000 000 cellules · 1 mL de dispersion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.